Skip to content

Effectiveness of Action Observation Therapy in Stroke Patients

Investigating the Effectiveness of Action Observation Therapy Applied in Addition to Conventional Treatment in Stroke Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06501014
Enrollment
30
Registered
2024-07-15
Start date
2024-07-16
Completion date
2025-09-30
Last updated
2025-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rehabilitation, Stroke

Brief summary

The goal of this clinical trial is to learn the effectiveness of action observation therapy in patients with stroke. The main questions it aims to answer are: Is action observation therapy an effective method in stroke patients? Researchers will compare the results of two action observation-based exercises (home program) with conventional exercise to see whether action observation therapy works in the rehabilitation of stroke patients. Participants: Participants in one group will do action observation-based exercise (home plus conventional exercise for 24 sessions, Patients in the control group will only undergo conventional exercise in addition to routine treatment.

Detailed description

Individuals with chronic stroke will be included in this study. Participants will be randomly divided into two groups, and patients in both groups will continue their routine treatments. Patients in the control group will only undergo conventional exercise. Patients in the study group will be given a home exercise program in addition to conventional treatment. However, patients will be asked to first watch the video of each exercise in this program and then perform the exercise. Patients will be asked to perform the exercises 3 days a week for 8 weeks. Evaluations will be made twice, before the exercise program application begins and after the sessions are completed.

Interventions

OTHERAction Observation Therapy-Experimental Group

Patients will be asked to watch the exercises before doing them.For each exercise, patients will first watch the relevant video and do the exercise after the video ends.

OTHERConventional Exercises-Control Group

Patients will be subjected to conventional exercise only.

Sponsors

KTO Karatay University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Stroke patients in the chronic phase (more than 6 months have passed since the stroke) * Patients over 40 years of age * Patients who can stand and walk independently (including those using walking aids)

Exclusion criteria

* Additional disease (neurological, orthopedic, etc.) that may affect motor performance and balance. * Patients with communication problems * Patients with mental problems (mini-mental test score \<23) * Patients aged 85 and over

Design outcomes

Primary

MeasureTime frameDescription
2 minute walk testThe evaluation will be applied at the baseline and after study completion, an average of 2 months.Patients will be asked to walk 30 meters long on a flat surface for 2 minutes. When the time is up, the distance the patient can walk will be recorded.
Fugl-Meyer AssessmentThe evaluation will be applied at the baseline and after study completion, an average of 2 months.The FMA motor assessments for the lower extremity (minimum score:0 and maximum score 34 points) will be applied. A higher score means the patient's motor movements are better.
Berg Balance ScaleThe evaluation will be applied at the baseline and after study completion, an average of 2 months.The Berg Balance Scale is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of funcion.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 21, 2026